1599 related articles for article (PubMed ID: 16243792)
21. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L
Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
23. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal abnormalities of clear cell renal cell carcinoma: frequent gain of chromosome 7.
Kuroda N; Tamura M; Shiotsu T; Nakamura S; Taguchi T; Tominaga A; Hes O; Michal M; Kawada C; Shuin T; Lee GH
Pathol Int; 2010 Jan; 60(1):9-13. PubMed ID: 20055946
[TBL] [Abstract][Full Text] [Related]
25. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
[TBL] [Abstract][Full Text] [Related]
27. Trisomy 7 and 17 mark papillary renal cell tumours irrespectively of variation of the phenotype.
Balint I; Szponar A; Jauch A; Kovacs G
J Clin Pathol; 2009 Oct; 62(10):892-5. PubMed ID: 19541684
[TBL] [Abstract][Full Text] [Related]
28. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors.
Presti JC; Rao PH; Chen Q; Reuter VE; Li FP; Fair WR; Jhanwar SC
Cancer Res; 1991 Mar; 51(5):1544-52. PubMed ID: 1671759
[TBL] [Abstract][Full Text] [Related]
29. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases.
Kovacs G
Am J Pathol; 1989 Jan; 134(1):27-34. PubMed ID: 2913826
[TBL] [Abstract][Full Text] [Related]
30. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
Xu XF; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
[TBL] [Abstract][Full Text] [Related]
31. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
[TBL] [Abstract][Full Text] [Related]
32. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
34. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
Cairns P; Tokino K; Eby Y; Sidransky D
Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
[TBL] [Abstract][Full Text] [Related]
35. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.
Bugert P; Kovacs G
Am J Pathol; 1996 Dec; 149(6):2081-8. PubMed ID: 8952540
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis.
Gobbo S; Eble JN; Maclennan GT; Grignon DJ; Shah RB; Zhang S; Martignoni G; Brunelli M; Cheng L
Am J Surg Pathol; 2008 Dec; 32(12):1780-6. PubMed ID: 18779729
[TBL] [Abstract][Full Text] [Related]
38. Multiple squamous cell carcinomas of the head and neck show different phenotypes of allelic loss patterns suggesting different clonal origin of carcinogenesis.
Shiga K; Ogawa T; Yoshida F; Matsuura K; Tateda M; Saijo S; Miyagi T; Kobayashi T
Anticancer Res; 2003; 23(5A):3911-5. PubMed ID: 14666696
[TBL] [Abstract][Full Text] [Related]
39. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT
Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319
[TBL] [Abstract][Full Text] [Related]
40. Multiple head and neck tumors: evidence for a common clonal origin.
Bedi GC; Westra WH; Gabrielson E; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2484-7. PubMed ID: 8653681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
